Infective endocarditis in congenital heart disease: a frequent community-acquired complication
- 787 Downloads
Infective endocarditis (IE) is a severe complication in patients with congenital heart disease (CHD). Epidemiology, etiology, and outcome in this group are different to those of patients with acquired heart disease.
We reviewed all cases of proven and probable IE (Duke’s criteria) diagnosed in our center during the last two decades.
We observed 45 cases of IE in patients with CHD (age range 8 months to 35 years); these represented 5.5 % of all the episodes of IE in our institution during the study period. The most frequent CHD were ventricular septal defect (31 %), tetralogy of Fallot (19 %), and atrioventricular septal defect (11 %). Twenty cases of IE (44 %) were recorded in patients with non-corrected native-valve CHD. Of the 24 patients with prosthetic-valve IE, post-operative acquisition during the first 6 months was confirmed in 11 patients (range 4–110 days). IE was community-acquired in 62 % of cases. Streptococcus spp. were the most frequent etiologic agents (33 %), followed by Staphylococcus spp. (32 %). Surgery was required to treat IE in 47 % of patients (52 % in prosthetic-valve IE and 41 % in native-valve IE, p = ns). In comparison to native-valve IE, prosthetic-valve IE was significantly more nosocomial-acquired (61 vs. 14 %, p = 0.002), presented a higher heart failure rate at diagnosis (39 vs. 9 %, p = 0.035), and developed more breakthrough bacteremia episodes (19 vs. 0 %, p = 0.048). Global mortality was 24 % (75 % in patients with prosthetic-valve IE who required surgery and 0 % in patients with native-valve IE who required surgery, p = 0.001). Multivariate analysis excluding breakthrough bacteremia (100 % mortality in this condition) confirmed that nosocomial IE [odds ratio (OR), 23.7; 95 % confidence interval (CI), 2.3–239.9] and the presence of heart failure at diagnosis of IE (OR, 25.9; 95 % CI, 2.5–269.6) were independent factors associated with mortality.
Half of all cases of IE in patients with CHD occurred in patients with non-corrected native-valve CHD and two-thirds were community-acquired. Streptococcus spp. were the most frequent etiological agents. Patients with prosthetic-valve IE present a worse outcome, especially those requiring surgery. Breakthrough bacteremia, nosocomial IE, and heart failure are independent factors of mortality in patients with CHD presenting IE.
KeywordsEndocarditis Congenital heart disease Prosthetic valve
Conflict of interest
The authors declare no conflicts of interest.
The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in Infection.
- 5.Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc. 2007;138(6):739–45, 747–60.PubMedGoogle Scholar
- 6.Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369–413.PubMedCrossRefGoogle Scholar
- 21.Ishiwada N, Niwa K, Tateno S, Yoshinaga M, Terai M, Nakazawa M; for The Japanese Society of Pediatric Cardiology and Cardiac Surgery Joint Working Groups for Guidelines for Prophylaxis, Diagnosis and Management of Infective Endocarditis in Patients With Congenital Heart Disease. Causative organism influences clinical profile and outcome of infective endocarditis in pediatric patients and adults with congenital heart disease. Circ J. 2005;69:1266–70.PubMedCrossRefGoogle Scholar
- 24.Menon T, Naveen Kumar V. Catonella morbi as a cause of native valve endocarditis in Chennai, India. Infection. 2012 Feb 25. [Epub ahead of print].Google Scholar
- 29.Leone S, Ravasio V, Durante-Mangoni E, Crapis M, Carosi G, Scotton PG, Barzaghi N, Falcone M, Chinello P, Pasticci MB, Grossi P, Utili R, Viale P, Rizzi M, Suter F. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian study on endocarditis. Infection. 2012 Jun 19. [Epub ahead of print].Google Scholar
- 30.Bouza E, Menasalvas A, Muñoz P, Vasallo FJ, Del Mar Moreno M, García Fernández MA. Infective endocarditis—a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore). 2001;80:298–307.CrossRefGoogle Scholar
- 31.Niwa K, Nakazawa M, Miyatake K, Tateno S, Yoshinaga M; Japanese Circulation Society (JCS) Joint Working Groups for Guidelines for Management of Infective Endocarditis; Japanese Society of Pediatric Cardiology and Cardiac Surgery Joint Working Groups for Guidelines for Prophylaxix, Diagnosis and Management of Infective Endocarditis in Patients with Congenital Heart Disease. Survey of prophylaxis and management of infective endocarditis in patients with congenital heart disease: Japanese nationwide survey. Circ J. 2003;67:585–91.PubMedCrossRefGoogle Scholar
- 34.Miro JM, Anguera I, Cabell CH, Chen AY, Stafford JA, Corey GR, et al; International Collaboration on Endocarditis Merged Database Study Group. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis. 2005;41:507–14.PubMedCrossRefGoogle Scholar